Tel: +44 (0) 7729 803482

Image description
Image description



Building, Managing & Monetizing your IP Portfolio



9.30am to 12.30pm
12 November 2018

London BioScience Innovation Centre

2 Royal College Street

NW1 0NH



Cost

 

£199 



Defining, implementing and executing your IP strategy is key to any technology based organisation.  Learn how to drive innovation, secure IP protection, grow the portfolio and extract value from your IP assets.






Who Should Attend?


The course is intended for R&D leaders, business development managers, 
technology transfer & licensing professionals, and IP managers who are responsible for IP portfolios, particularly patent portfolios.








Outline of Course


Topics and group exercises include:


  • Defining your IP Strategy
  • Securing Protection
  • Trade Secrets vs. Patent Protection
  • Growing your Portfolio
  • Organic versus Inorganic Growth
  • Fostering Innovation
  • Collaborating
  • Open Innovation 
  • Managing Costs
  • Working with External IP Counsel
  • Reviewing and Evaluating the Portfolio
  • Monetizing your Portfolio
  • Licensing
  • SEPs, FRAND, Patent Pools

 

 


Program Download


 

 

 

Freedom to Operate 




9.30am to 5pm

3 December 2018

London 

 

 



Cost


£299



Learn how to identify and deal with third party engineering, device and software patents in the Engineering and Manufacturing industries.


 

 


Who Should Attend?


R&D scientists & engineers, program managers, technology transfer & licensing professionals, business development managers, IP managers, trainee patent attorneys and legal professionals working in the Engineering and Manufacturing industries.

 

 Outline of Course


Topics and group exercises include:


  • IP Rights in the Engineering Industries
  • Software Patents
  • SEPs and FRAND
  • Ownership of IP Rights
  • How to Read a Patent & Interpret Claims
  • Patent Term/ determining if Patents in Force
  • Patentability versus Freedom to Operate
  • Freedom to Operate Searches
  • Validity Searches
  • Infringement of IP Rights
  • Enforcement of IP Rights
  • Actavis v. Eli Lilly - Doctrine of Equivalents
  • Dealing with Third Party Patents
  • Design Arounds
  • Unitary Patent Stystem
  • Brexit
  • Challenging Patents in Europe and the US
  • FTO Exercises


Program Download


Managing Your IP Portfolio Program.pdf
Enter file download description here
Freedom to Operate Program.pdf
Enter file download description here



In-House Courses

 

We offer a range of in-house IP courses which can be tailored to suit your training requirements and given at your premises. We'd be pleased to discuss your training needs and design the most appropriate course for you.  Please call or email us to start this discussion.

 

 

Freedom to Operate for the Life Sciences and Pharmaceutical Industries

 

9.30am to 5pm

15 October 2018

London BioScience Innovation Centre

2 Royal College Street

NW1 0NH

 


Cost


£299



Learn how to identify and deal with third party chemical, biological and device patents in the Life Sciences and Pharmaceutical industries.

 



Who Should Attend?

 

R&D scientists & engineers, business development managers, technology transfer and licensing professionals, IP analysts, trainee patent attorneys & legal advisors working in the Life Sciences and the Pharmaceutical sectors.


 Outline of Course

 

Topics and group exercises include: 


  • Life Sciences & Pharma IP Rights
  • Patent Term Extension (SPCs)
  • Ownership of IP Rights
  • How to Read a Patent
  • Interpreting Claims
  • Freedom to Operate Searches
  • Patent Term and Status
  • Validity Searches
  • Infringement of IP Rights
  • Enforcement of IP Rights
  • Actavis v. Eli Lilly - Doctrine of Equivalents
  • Dealing with Third Party Patents
  • Design Arounds
  • Unitary Patent System 
  • Brexit
  • Challenging Patents in EU & US
  • CRISPR IP Landscape
  • FTO Exercises

 

 Program Download


Freedom to Operate for LS&P Program.pdf
Enter file download description here


"I thoroughly enjoyed the course which was really well thought out" 


Dr Alan Stuttle, Business Development Manager, Institute of Cancer Research. March 2017